Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 566 - файл
.pdf
286
https://t.me/medicina_free
2. Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ,
Pandolno JE, International High Resolution Manometry Working
Group. The Chicago classication of esophageal motility disorders, v3.0.
Neurogastroenterol Motil. 2015;27(2):160–74. https://doi.org/10.1111/
nmo.12477. Epub 2014 Dec 3.
3. Jia Y, Arenas J, Hejazi RA, Elhana S, Saadi M, McCallum
RW.Frequency of jackhammer esophagus as the extreme phenotypes of
esophageal hypercontractility based on the new Chicago classication.
J Clin Gastroenterol. 2016;50(8):615–8. https://doi.org/10.1097/
MCG.0000000000000496.
4. Kamal A, Shakya S, Lopez R, Thota PN.Gender, medication use and
other factors associated with esophageal motility disorders in nonobstructive dysphagia. Gastroenterol Rep (Oxf). 2018;6(3):177–83.
https://doi.org/10.1093/gastro/goy018. Epub 2018 Jun 2.
5. Kristo I, Schwameis K, Maschke S, Kainz A, Rieder E, Paireder M,
Jomrich G, Schoppmann SF. Phenotypes of jackhammer esophagus in
patients with typical symptoms of gastroesophageal reux disease
responsive to proton pump inhibitors. Sci Rep. 2018;8(1):9949. https://
doi.org/10.1038/s41598- 018- 27756- 9.
6. Clément M, etal. Jackhammer esophagus: from manometric diagnosis to
clinical presentation. Can J Gastroenterol Hepatol. 2019;2019:5036160.
PMID: 30941328.
7. Al-Qaisi MT, Siddiki HA, Crowell MD, Burdick GE, Fleischer DE,
Ramirez FC, Vela MF.The clinical signicance of hypercontractile peristalsis: comparison of high-resolution manometric features, demographics, symptom presentation, and response to therapy in patients with
jackhammer esophagus versus nutcracker esophagus. Dis Esophagus.
2017;30(12):1–7. https://doi.org/10.1093/dote/dox085.
8. Sato H, Takeuchi M, Takahashi K.Eosinophilic inltration of the muscularis propria in a patient with jackhammer esophagus treated with perOral endoscopic myotomy. Clin Gastroenterol Hepatol. 2015;13(4):e33–4.
https://doi.org/10.1016/j.cgh.2014.11.005. Epub 2014 Nov 12.
9. Woo M, Andrews CN, Buresi M.Reversible jackhammer esophagus in a
patient with a gastric band. Neurogastroenterol Motil. 2019;31(4):e13572.
https://doi.org/10.1111/nmo.13572.
10. Huang L, Pimentel M, Rezaie A.Do jackhammer contractions lead to
achalasia? A longitudinal study. Neurogastroenterol Motil. 2017;29(3)
https://doi.org/10.1111/nmo.12953. Epub 2016 Sep 23.
11. Abdallah J, Fass R. Progression of jackhammer esophagus to type II
achalasia. J Neurogastroenterol Motil. 2016;22(1):153–6. https://doi.
org/10.5056/jnm15162.
12. Huang L, Rezaie A.Progression of jackhammer esophagus to achalasia.
J Neurogastroenterol Motil. 2016;22(2):348–9. https://doi.org/10.5056/
jnm16021.
S. A. Abel and J. R. Broucek

20 Jackhammer Esophagus
https://t.me/medicina_free
13. Amieva-Balmori M, Cano-Contreras AD, Remes-Troche JM.
“Jackhammer esophagus” and eosinophilic esophagitis. Rev Gastroenterol
Mex. 2015;80(3):217–9. https://doi.org/10.1016/j.rgmx.2015.03.006.
Epub 2015 Aug 12.
14. Snyder DL, Crowell MD, Horsley-Silva J, Ravi K, Lacy BE, Vela
MF.Opioid-induced esophageal dysfunction: differential effects of type
and dose. Am J Gastroenterol. 2019;114(9):1464–9. https://doi.
org/10.14309/ajg.0000000000000369.
15. Herregods TVK, Smout AJPM, Ooi JLS, Sifrim D, Bredenoord
AJ. Jackhammer esophagus: observations on a European Cohort.
Neurogastroenterol Motil. 2017;29(4) https://doi.org/10.1111/
nmo.12975. Epub 2016 Oct 17.
16. Almansa C, Heckman MG, DeVault KR, Bouras E, Achem SR.Esophageal
spasm: demographic, clinical, radiographic, and manometric features in
108 patients. Dis Esophagus. 2012;25(3):214–21. https://doi.org/10.1111/
j.1442- 2050.2011.01258.x. Epub 2011 Sep 23.
17. Csucska M, Masuda T, Bremner RM, Mittal SK.Clinical symptom presentation of hypercontractile peristalsis in the era of high-resolution
manometry: a single-center experience. Dig Dis. 2020;38:355–63. https://
doi.org/10.1159/000505123.
18. Sato H, Hasegawa G, Takeuchi M, Takahashi K, Sato Y, Hashimoto S,
Mizuno K, Kobayashi M.Education and imaging. Gastroenterology: a
unique endoscopic technique for full-layer histology of jackhammer
esophagus. J Gastroenterol Hepatol. 2015;30(8):1226. https://doi.
org/10.1111/jgh.12914.
19. García-Lledó J, Clemente-Sánchez A, Merino-Rodríguez B, NogalesRincón Ó, González-Asanza C, Menchén-Fernández-Pacheco
P. Hypercontractile “jackhammer esophagus”. Rev Esp Enferm Dig.
2015;107(4):234. PMID: 25824925.
20. Kim JH, Kim SE, Cho YK, Lim C-H, In Park M, Hwang JW, Jang J-S,
Minkyung O, Motility Study Club of Korean Society of
Neurogastroenterology and Motility. Factors determining the interobserver variability and diagnostic accuracy of high-resolution manometry for esophageal motility disorders. J Neurogastroenterol Motil.
2018;24(1):58–69. https://doi.org/10.5056/jnm17064.
21. Mauro A, Quader F, Tolone S, Savarino E, De Bortoli N, Marianna
Franchina C, Gyawali P, Penagini R.Provocative testing in patients with
jackhammer esophagus: evidence for altered neural control. Am J Physiol
Gastrointest Liver Physiol. 2019;316(3):G397–403. https://doi.
org/10.1152/ajpgi.00342.2018. Epub 2018 Dec 13.
22. Goel R, Anggiansah A, Wong T, Wilkinson M.A jackhammer in the gullet: high amplitude oesophageal contractions as a cause of atypical chest
pain. BMJ Case Rep. 2015;2015:bcr2015210631. https://doi.org/10.1136/
bcr- 2015- 210631.
287

288
https://t.me/medicina_free
23. Carlson DA, Gluskin AB, Mogni B, Koo J, Sood R, Lin Z, Pandolno
JE.Esophageal diverticula are associated with propagating peristalsis: a
study utilizing high-resolution manometry. Neurogastroenterol Motil.
2016;28(3):392–8. https://doi.org/10.1111/nmo.12739. Epub 2015 Dec
8.
24. Mallet A-L, Ropert A, Bouguen G, Siproudhis L, Boutroux D, Bretagne
J-F, Brochard C.Prevalence and characteristics of acid gastro- oesophageal
reux disease in jackhammer oesophagus. Dig Liver Dis.
2016;48(10):1136–41. https://doi.org/10.1016/j.dld.2016.06.030. Epub
2016 Jul 9.
25. Hong YS, Min YW, Rhee P-L.Two distinct types of hypercontractile
esophagus: classic and spastic jackhammer. Gut Liver. 2016;10(5):859–
63. https://doi.org/10.5009/gnl15388.
26. Roman S, Kahrilas PJ.Management of spastic disorders of the esophagus. Gastroenterol Clin North Am. 2013;42(1):27–43. https://doi.
org/10.1016/j.gtc.2012.11.002. Epub 2013 Jan 4. PMID: 23452629;
PMCID: PMC3618975.
27. Swamy N.Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites. Gastroenterology. 1977;72(1):23–7.
PMID: 401445.
28. Hosaka H, Kawami N, Manabe N, Kuribayashi S, Sato H, Funaki Y,
Ayaki M, Hara K, Ueda C, Matsumura T, Fujiwara Y, Wada M, Kishino
M, Yano F, Masaoka T, Ishimura N, Akiyama J, Ochiai Y, Uraoka T,
Iwakiri K.Clinical presentation and therapeutic outcome of patients with
jackhammer esophagus-a multicenter cohort study in Japan. Esophagus.
2022;19(3):393–400. https://doi.org/10.1007/s10388- 022- 00916- 7. Epub
2022 Mar 6. PMID: 35249162; PMCID: PMC9166863.
29. Babaei A, Shad S, Massey BT.Esophageal hypercontractility is abolished
by cholinergic blockade. Neurogastroenterol Motil. 2021;33(8):e14017.
https://doi.org/10.1111/nmo.14017. Epub 2020 Nov 13. PMID:
33185322.
30. Funaki Y, Ogasawara N, Kawamura Y, Yoshimine T, Tamura Y, Izawa S,
Tsuyuki T, Ebi M, Sasaki M, Kasugai K.Markedly effective steroid treatment of three patients with allergy-related jackhammer esophagus. Intern
Med. 2020;59(5):633–9. https://doi.org/10.2169/internalmedicine.3865-
19. Epub 2019 Nov 8.
31. Sato H, Takeuchi M, Takahashi K, Sato Y, Hashimoto S, Mizuno K,
Suzuki K, Kobayashi M, Honma T, Inoue H, Terai S.Nutcracker and
jackhammer esophagus treatment: a three-case survey, including two
novel cases of eosinophilic inltration into the muscularis propria.
Endoscopy. 2015;47(9):855–7. https://doi.org/10.1055/s- 0034- 1391985.
Epub 2015 May 11.
32. Tanaka S, Toyonaga T, Kawara F, Watanabe D, Hoshi N, Abe H, Ariyoshi
R, Ohara Y, Ishida T, Takao T, Morita Y, Umegaki E.A case of jackhammer esophagus caused by eosinophilic esophagitis in which per-oral
S. A. Abel and J. R. Broucek

20 Jackhammer Esophagus
https://t.me/medicina_free
endoscopic myotomy resulted in symptom improvement. Clin J
Gastroenterol. 2018;11(5):377–81. https://doi.org/10.1007/s12328- 018-
0868- y. Epub 2018 May 22.
33. Zerbib F, Roman S.Current therapeutic options for esophageal motor disorders as dened by the Chicago classication. J Clin Gastroenterol.
2015;49(6):451–60. https://doi.org/10.1097/MCG.0000000000000317.
34. Kawami N, Hoshino S, Hoshikawa Y, Takenouchi N, Hanada Y, Tanabe T,
Koeda M, Monma E, Goto O, Kaise M, Iwakiri K.Differences in clinical
characteristics between conservative-treatment-response group and
refractory (surgical-treatment) group in patients with jackhammer esophagus. Esophagus. 2021;18(1):138–43. https://doi.org/10.1007/s10388-
020- 00748- 3. Epub 2020 May 26. PMID: 32458101.
35. Sakai Y, Tsuyuguchi T, Ishihara T, Kato K, Tsuboi M, Ooka Y, Katsuura
K, Ohara T, Takayama S, Kimura M, Kasanuki J, Ai M, Yokosuka
O.Conrmation of the antispasmodic effect of shakuyaku-kanzo-to (TJ-
68), a Chinese herbal medicine, on the duodenal wall by direct spraying
during endoscopic retrograde cholangiopancreatography. J Nat Med.
2009;63(2):200–3. https://doi.org/10.1007/s11418- 008- 0304- 6. Epub
2008 Dec 3. PMID: 19050990.
36. Feng J, Ali RW, Hao J-y, Kong G-x, Yang L-h, Huang X-j. Peroral endoscopic myotomy for esophageal motility disorders. Esophagus.
2020;17(1):11–8. https://doi.org/10.1007/s10388- 019- 00693- w.
37. Khan M, A, Kumbhari V, Ngamruengphong S, Ismail A, Chen Y-I,
Chavez YH, Bukhari M, Nollan R, Ismail MK, Onimaru M, Balassone V,
Sharata A, Swanstrom L, Inoue H, Repici A, Khashab MA.Is POEM the
answer for management of spastic esophageal disorders? A systematic
review and meta-analysis. Dig Dis Sci. 2017;62(1):35–44. https://doi.
org/10.1007/s10620- 016- 4373- 1. Epub 2016 Nov 17.
38. Bechara R, Ikeda H, Inoue H.Peroral endoscopic myotomy for jackhammer esophagus: to cut or not to cut the lower esophageal sphincter.
Endosc Int Open. 2016;4(5):E585–8. https://doi.
org/10.1055/s- 0042- 105204. Epub 2016 Apr 8. PMID: 27274539.
39. Khashab MA, Familiari P, Draganov PV, Aridi HD, Cho JY, Ujiki M,
Tinto RR, Louis H, Desai PN, Velanovich V, Albéniz E, Haji A, Marks J,
Costamagna G, Devière J, Perbtani Y, Hedberg M, Estremera F, Martin
Del Campo LA, Yang D, Bukhari M, Brewer O, Sanaei O, Fayad L,
Agarwal A, Kumbhari V, Chen Y-I.Peroral endoscopic myotomy is effective and safe in non-achalasia esophageal motility disorders: an international multicenter study. Endosc Int Open. 2018;6(8):E1031–6. https://
doi.org/10.1055/a- 0625- 6288. Epub 2018 Aug 10.
40. Khashab MA, Messallam AA, Onimaru M, Teitelbaum EN, Ujiki MB,
Gitelis ME, Modayil RJ, Hungness ES, Stavropoulos SN, El Zein MH,
Shiwaku H, Kunda R, Repici A, Minami H, Chiu PW, Ponsky J, Kumbhari
V, Saxena P, Maydeo AP, Inoue H.International multicenter experience
with peroral endoscopic myotomy for the treatment of spastic esophageal
289

290
https://t.me/medicina_free
disorders refractory to medical therapy (with video). Gastrointest Endosc.
2015;81(5):1170–7. https://doi.org/10.1016/j.gie.2014.10.011. Epub
2015 Jan 26.
41. Ramos RI, Guidi M, Kakisu MH, Rocca AM, Sakai P.Peroral endoscopic
myotomy in pediatric jackhammer esophagus. Rev Esp Enferm Dig.
2018;110(7):464–5. https://doi.org/10.17235/reed.2018.5090/2017.
PMID: 29667413.
42. Estremera-Arévalo F, Albéniz E, Rullán M, Areste I, Iglesias R, Vila
JJ.Efcacy of peroral endoscopic myotomy compared with other invasive treatment options for the different esophageal motor disorders. Rev
Esp Enferm Dig. 2017;109(8):578–86. https://doi.org/10.17235/
reed.2017.4773/2016.
43. García PV, de Los Ríos CC, Rodríguez-Valcárcel FC, García-Gallardo
DH. Progression of jackhammer esophagus to type III achalasia and
improvement after extended myotomy. J Neurogastroenterol Motil.
2020;26(1):164–6. https://doi.org/10.5056/jnm19156.
44. Chandan S, Mohan BP, Chandan OC, Jha LK, Mashiana HS, Hewlett AT,
Khashab MA.Clinical efcacy of per-oral endoscopic myotomy (POEM)
for spastic esophageal disorders: a systematic review and meta-analysis.
Surg Endosc. 2020;34(2):707–18. https://doi.org/10.1007/s00464- 019-
06819- 6. Epub 2019 May 9.
45. Sato H, Takahashi K, Mizuno K-I, Hashimoto S, Yokoyama J, Hasegawa
G, Terai S.Esophageal motility disorders: new perspectives from highresolution manometry and histopathology. J Gastroenterol.
2018;53(4):484–93. https://doi.org/10.1007/s00535- 017- 1413- 3. Epub
2017 Nov 13.
S. A. Abel and J. R. Broucek

Secondary Esophageal
https://t.me/medicina_free
Motility Disorders:
21
Diagnosis andManagement
MeredithA.Harrison, RonakModi,
RodrigoDuarte-Chavez,
andAndrewM.Brown
Introduction
Disorders of esophageal motility are dened by using high resolution manometry (HRM) with color pressure topography plots and
categorized according to version 3.0 of the Chicago Classication
of esophageal motility disorders, last updated in 2014 [1]. Using
a tiered approach, the Chicago Classication system denes the
primary esophageal motility disorders. In addition to those major
and minor disorders, there are other systemic and localized
pathologies which secondarily lead to disorders of motility. As a
result of these secondary esophageal motility disorders being rel-
M. A. Harrison · A. M. Brown (*)
Department of Surgery, St. Luke’s University Hospital,
Bethlehem, PA, USA
e-mail: Meredith.harrison@sluhn.org; andrew.brown2@sluhn.org
R. Modi · R. Duarte-Chavez
Department of Gastroenterology, St. Luke’s University Hospital,
Bethlehem, PA, USA
e-mail: Ronak.Modi@sluhn.org; Rodrigo.Chavez@sluhn.org
© Society of American Gastrointestinal and Endoscopic Surgeons
(SAGES) 2023
A. D. Patel et al. (eds.), The SAGES Manual of Physiologic
Evaluation of Foregut Diseases,
https://doi.org/10.1007/978-3-031-39199-6_21
291

292
https://t.me/medicina_free
M. A. Harrison et al.
atively rare, diagnoses can often be delayed, and management can
be challenging. The knowledgeable foregut surgeon should be
prepared for the complexities of these conditions and able to treat
these patients in conjunction with a multidisciplinary team.
Case #1
Patient Information
A 62-year-old female presents to the outpatient ofce with
atypical chest pain and dysphagia to solids and liquids associated
with uncontrollable heartburn despite medical therapy. Physical
exam reveals telangiectasia, muscle atrophy with sclerodactyly,
and Raynaud phenomenon. On laboratory workup, anticentromere antibodies were positive.
Manometry
Figure 21.1 shows the HRM for this patient. By Chicago classication, this patient has ineffective esophageal motility with
scleroderma pattern. The mean distal contractile integral (DCI)
for this patient was 50 mmHg/s/cm, with a median integrated
relaxation pressure (IRP) of 1mmHg.
Fig. 21.1 High Resolution Manometry in Scleroderma. Mean DCI:
50mmHg/s/cm, Median IRP: 1mmHg

21 Secondary Esophageal Motility Disorders: Diagnosis…
https://t.me/medicina_free
293
Background
Systemic Sclerosis (SSc) or Scleroderma is a connective tissue
disorder with 8:2 female to male predominance and documented
histological esophageal involvement in up to 90% of patients [2].
While the percentage of histologic involvement of the esophagus in patients with SSc is quite high, the incidence of esophageal
symptoms ranges from 40 to 80%. Patients with esophageal dysfunction have two broad categories of symptoms: heartburn and
regurgitation secondary to gastroesophageal reux disease
(GERD), or dysphagia and chest pain secondary to esophageal
dysmotility [2].
Workup can include pH testing with or without impedance and
upper endoscopy, but manometry is imperative. Classic scleroderma esophagus is characterized by absent or ineffective peristalsis with a hypotensive lower esophageal sphincter (LES). A
hypotensive LES is dened as less than 10mmHg. Upwards of
50% of symptomatic patients will present with this manometric
pattern. Additionally, chest CT may reveal a dilated esophagus in
>70% of patients who present with the classic scleroderma esophagus pattern on esophageal manometry [3].
Management is aimed at symptom improvement, either managing GERD symptoms or dysmotility symptoms. GERD management is centered on proton pump inhibitor (PPI) therapy, but
although there is short term benet, the long-term efcacy is not
sustained, and there is no prevention of progression of esophageal
dysfunction [4, 5]. Common practice includes a 2–4× increase in
the daily dose of PPI to gain better symptom control [6]. Surgical
management for GERD symptoms of SSc should avoid anti-reux
procedures such as Nissen fundoplication, as 38–71% of patients
can develop postoperative dysphagia despite improvement of
reux symptoms [7–9]. Some authors advocate Roux-en-y gastric
bypass to prevent reux, which has been shown to have better
post-op GER-related quality of life and less dysphagia as compared to Nissen [10]. However, bypass in a scleroderma patient
should be pursued with caution given the propensity of small
intestinal dysmotility in SSc patients. An esophagectomy can be
considered for end-stage scleroderma of the esophagus.

294
https://t.me/medicina_free
M. A. Harrison et al.
Esophageal dysmotility symptoms can be improved with various prokinetic drugs such as metoclopramide, erythromycin, and
cisapride [11–13]. Ciaspride has been shown to increase LES
pressure and the amplitude of distal esophageal body peristalsis in
SSc patients [11, 14]. Domperidone, a peripheral dopamine
antagonist, is commonly used, but the literature questions the
effect of symptom and manometric improvement of this drug’s
administration [15]. An emerging therapy, buspirone a
5- hydroxytryptamine 1A (5-HT1A) agonist, has been shown to
increase LES resting pressure and improve the severity of heartburn and regurgitation in SSc patients in small studies [16].
Case #2
Patient Information
A 39-year-old male presents to the ofce with complaints of
signicant heartburn and regurgitation. His medical history is signicant for chronic GERD on medical therapy and obesity, with a
social history signicant for smoking.
Manometry
Figure 21.2 shows the HRM for this patient. The manometry
pinpoints a specic reux event.
Fig. 21.2 High Resolution Manometry in GERD. Arrow indicates a reux
event during study.

21 Secondary Esophageal Motility Disorders: Diagnosis…
https://t.me/medicina_free
295
Background
Gastroesophageal reux disease (GERD), while highly prevalent in Western countries, displays heterogeneity in terms of clinical features, pathophysiologic mechanisms, and response to acid
suppression [17]. The pathogenesis is multifactorial, but includes:
transient lower esophageal sphincter (LES) relaxations, hypotension of the LES, impairment of the gastroesophageal junction
(i.e., hiatal hernia), ineffective esophageal acid and bolus clearance, delayed gastric emptying, and impaired mucosal defensive
factors. The major mechanisms for esophageal dysmotility in
GERD are due to impairments at the gastroesophageal junction
(transient LES relaxation, hypotensive LES, or hiatal hernia) and
ineffective esophageal motility [17–19]. Furthermore, persistent
injury to the esophageal mucosa is associated with dysmotility.
Transient LES relaxations are 10–60s periods of LES relaxation that are not preceded by a swallow and are deemed spontaneous [20]. These episodes make up the majority of the periods of
reux in patients with moderate GERD.As the severity of GERD
increases, a hypotensive LES becomes the prevalent
pathophysiological mechanism. Dened as an LES basal pressure
less than 10mmHg, a hypotensive LES is found with increasing
prevalence as the severity of GERD increases, such as in patients
with Barrett’s esophagus, erosive esophagitis, and nonerosive
reux disease [21, 22].
Ineffective esophageal motility, dened as hypocontractility in
greater than 30% of swallows, is the most prevalent esophageal
motor disorder in GERD [23, 24]. Furthermore, worsening peristaltic dysfunction is increasingly prevalent with more severe
GERD [21, 23, 25, 26]. When contractility is preserved, major
peristaltic breaks can be observed resulting in fragmented peristalsis [27].
Diagnosis of esophageal dysmotility in the setting of GERD is
done with high resolution manometry, often combined with
impedance, which can help identify abnormal bolus transport and
clearance during swallows and investigate the relationships
between bolus transit and LES relaxation [28]. Treatment with a
proton pump inhibitor will decrease acid exposure, but does not
improve esophageal dysmotility. Additionally, weight loss will
Соседние файлы в папке @xirurgi_2025
